Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Clinical Trial to Slow the Progression of ADPKD

Study:

n/a

Rationale:

n/a

Purpose:

This study will determine whether certain blood pressure medications will slow cyst growth or keep kidneys functioning longer in patients with autosomal dominant polycystic kidney disease (ADPKD). The study will take place at several sites in the United States. The start date of the study has not yet been determined.

Study Status: Not yet recruiting

Recruiting:
n/a

Condition Intervention Phase
Kidney, Polycystic
Kidney, Polycystic, Autosomal Dominant
Drug: anti-hypertensive medications N/A

Verified by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) November, 2005

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov identifier: NCT00067977

Study Type: Interventional

Study Design: Treatment, Active Control

Cleveland Clinic Foundation
Cleveland, Ohio
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site